FDA Drug Application (061396) for VERSAPEN-K by BRISTOL

Back to FDA Applications sponsored by BRISTOL

Application Number061396
Product Number001
FormCAPSULE;ORAL
DosageEQ 225MG AMPICIL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVERSAPEN-K
Active IngredientHETACILLIN POTASSIUM



Back to FDA Applications sponsored by BRISTOL